On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with multiple regulatory filing submissions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback